At-Home Skyrizi Induction Approved for Crohn’s After 56% Reached Clinical Remission at 12 Weeks Versus 30% on Placebo

FDA approved at-home Skyrizi induction for Crohn’s, with 56% reaching remission vs. 30% on placebo. What the results mean and key safety notes.

Have A Referral?